-
Dec 1, 2024 | 
link.springer.com | Rheumatology Research |a Johnson |Drexel College
AbstractPsoriatic arthritis (PsA) is a chronic, multidomain, inflammatory disease requiring long-term treatment. Guselkumab, a fully human interleukin [IL]-23p19-subunit inhibitor, and the IL-17A inhibitors (IL-17Ai) ixekizumab and secukinumab are approved by the US Food and Drug Administration (FDA) for adults with active PsA. Real-world data evaluating on-label treatment persistence is an important consideration for patients.
-
Oct 9, 2024 | 
virologyj.biomedcentral.com | Drexel College
Gorecka MM, Thirunavukarasu S, Levelt E, Greenwood JP. Progressive myocardial dysfunction following COVID-19. BMJ Case Rep. 2021;14(11):e246291. https://doi.org/10.1136/bcr-2021-246291 Gaine S, Devitt P, Coughlan JJ, Pearson I. COVID-19-associated myocarditis presenting as new-onset heart failure and atrial fibrillation. BMJ Case Rep. 2021;14(7):e244027. https://doi.org/10.1136/bcr-2021-244027 Dalen H, Holte E, Guldal AU, et al.
-
Jul 30, 2024 | 
link.springer.com | a Johnson |Drexel College
AbstractTreatment persistence among patients with psoriatic arthritis (PsA) is essential for achieving optimal treatment outcomes. Guselkumab, a fully human interleukin-23p19-subunit inhibitor, was approved by the United States (US) Food and Drug Administration for the treatment of active PsA in July 2020, with a dosing regimen of 100 mg at week 0, week 4, then every 8 weeks.
-
Jul 21, 2024 | 
link.springer.com | Drexel College
AbstractReports of mistreatment are an important first step to improving medical students’ learning environment. Students may not report mistreatment due to a lack of awareness of institutional policies, reporting procedures, or for fear of reprisal. We sought to determine if a medical school cross-platform mobile application (app) could be used to improve students’ awareness of mistreatment policies and procedures.
-
Mar 20, 2024 | 
onlinelibrary.wiley.com | Jaime Jordan |Jack Buckanavage |Drexel College |Jonathan S. Ilgen
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. Supporting Information Filename Description AET210956-sup-0001-Appendix A.docxWord 2007 document , 14.6 KB Appendix A. REFERENCES 1 Fellowship Directory. Society for Academic Emergency Medicine. Accessed November 24, 2023. https://member.saem.org/SAEMIMIS/SAEM_Directories/Fellowship_Directory/SAEM_Directories/P/FellowshipMap.aspx?hkey=573c442c-03ee-4c33-934a-5fda0b280835 2 EMRA Match.
-
Mar 13, 2024 | 01146-6/abstract?rss=yes&sz=64)
biologicalpsychiatryjournal.com | Nancy Mack |Drexel College |Nadia Bouras |Wen-Jun Gao
• None Enhanced neuronal activity in the medial prefrontal cortex during social approach behavior. The Journal of neuroscience : the official journal of the Society for Neuroscience. :• None Inhibitory Gating of Basolateral Amygdala Inputs to the Prefrontal Cortex. The Journal of neuroscience : the official journal of the Society for Neuroscience. :• None Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression.
-
Nov 22, 2023 | 
jamanetwork.com | Ali Shields |Drexel College |April W. Armstrong |Alison M. Layton
Key PointsQuestion
Is the DermSat-7, a 7-item questionnaire specific for dermatological conditions, adequate for assessing treatment satisfaction in patients with acne? Findings
In this cross-sectional study of 142 adults taking acne medication, the DermSat-7 had good structural validity and internal consistency for each of its 3 domains (effectiveness, convenience, and overall satisfaction).
-
Sep 15, 2023 | 
arthritis-research.biomedcentral.com | Universitätsklinikum Erlangen |Janssen Research |Spring House |Drexel College
Arthritis Research & Therapy volume 25, Article number: 170 (2023) Cite this article The Original Article was published on 16 August 2023 Correction: Arthritis Res Ther 25, 150 (2023) https://doi.org/10.1186/s13075-023-03125-4 Following publication of the original article [1], the authors reported that the corrections were not carried out during the revisions. The corrections are provided below and the changes have been set in bold typeface.
-
Apr 5, 2023 | 
academic.oup.com | Drexel College
We read Gupta et al's manuscript on ChatGPT (OpenAI; San Francisco, CA) with anticipation and excitement.1 They built upon their previous article about utilizing ChatGPT to develop ideas for systematic reviews.2,3 This iteration had the chatbot generate 10 specific and 10 general systematic reviews for 12 different cosmetic surgery ideas.
-
Mar 11, 2023 | 
academic.oup.com | Drexel College
We read with interest the recently published Aesthetic Surgery Journal article on OpenAI's ChatGPT chatbot (OpenAI; San Francisco, CA).1 Gupta and colleagues introduce a unique case of leveraging ChatGPT to write cosmetic surgery systematic reviews, and in this way generate novel ideas for research in areas that have not been investigated.
